Dagmar García-Rivera - Academia.edu (original) (raw)

Uploads

Papers by Dagmar García-Rivera

Research paper thumbnail of From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, Jan 27, 2017

A new pneumococcal conjugate vaccine is currently undergoing advanced clinical evaluation prior t... more A new pneumococcal conjugate vaccine is currently undergoing advanced clinical evaluation prior to its planned introduction in Cuba. The implementation of the pneumococcal vaccination strategy has been designed with consideration of the need to maximize both its direct and indirect effects. A novel approach is suggested, which addresses preschool children as the first-line target group to generate herd immunity in infants and to have an impact on transmission at the community level. The clinical evaluation pipeline is described herein, including evaluations of effectiveness, cost-effectiveness, and impact. The scientific contribution of the Cuban strategy could support a paradigm shift from individual protection to a population effect based on a rigorous body of scientific evidence.

Research paper thumbnail of Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2–18 Months of Age Baseline Study Pre Introduction of Pneumococcal Vaccination in Cuba

Background: A new vaccine candidate against pneumococcus is being developed in Cuba, and it is a ... more Background: A new vaccine candidate against pneumococcus is being
developed in Cuba, and it is a priority of the national health system. There is limited information on nasopharyngeal colonization burden, though it is essential for monitoring the impact of the vaccine. The study aims to estimate the prevalence of nasopharyngeal colonization in children 2–18 months of age and identify circulating serotypes, antimicrobial resistance and its association with selected risk factors.
Methods: A cross-sectional study was conducted between October and December 2013 in Cienfuegos municipality. Inclusion criteria were evaluated, and informed consent was obtained from the parents. Clinical and epidemiologic data were collected through a semistructured questionnaire. Nasopharyngeal swabs according to established protocols were taken. Data analysis included frequency
distributions and comparison of proportions. The association between
colonization and selected risk factors was assessed by multivariate analysis.
Results: A total of 984 children (87.2% living in urban areas) were included. The overall prevalence of colonization was 21.6%. The most frequent serotypes isolated were 6A (23.1%), 23F (10.8%), 6B (10.3%), 19F (8.5%) and 14 (3.3%). We found no resistance to β-lactamases in circulating serotypes. Living with sibling younger than 5 years, previous respiratory infections, previous hospitalization and day-care attendance were determinants of nasopharyngeal carriage.
Conclusions: The findings suggest that the burden of pneumococcal disease and colonization in Cuba could be significantly affected after vaccine introduction.

Research paper thumbnail of Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection

Heliyon, 2017

Streptococcus pneumoniae is a human pathogen responsible for the majority of childhood pneumonia ... more Streptococcus pneumoniae is a human pathogen responsible for the majority of childhood pneumonia and media otitis cases worldwide. The diversity of its capsular polysaccharides (CPS) results in more than 91 serotypes of which at least 23 are virulent. Various CPS conjugated to immunogenic carrier proteins are currently licensed and provide protection against the infection caused by the respective serotypes but not against new and emerging virulent serotypes. In this study, we considered the conserved protein antigen PsaA, the pneumococcal surface adhesin A, in order to overcome the limitations of CPS antigens. The PsaA was translationally fused to a polyhydroxybutyrate (PHB) synthase which mediated production of PsaA displayed on PHB inclusions in recombinant Escherichia coli. This suggested that the PsaA fusion to the PHB synthase did not interfere with PHB synthase activity and its ability to mediate formation of nano-sized inclusions composed of a PHB core surrounded by the PHB synthase fused to PsaA. Isolated PHB beads showed a negative surface charge. Transmission electron microscopy analysis suggested that the PsaA fusion to the PHB synthase reduced the size of PHB beads from about 500 nm to 100 nm. The integrity and antigenicity of the fusion protein attached to isolated PHB beads was confirmed by SDS-PAGE, tryptic peptide fingerprinting analysis using MALDI-TOF-MS/MS and immunoblotting using a monoclonal anti-PsaA antibody. Mice immunized with PsaA displaying PHB beads produced high and specific IgG levels dominated by IgG1 isotype. While IgG1 titer were similar between soluble and insoluble PsaA, the IgG2 titers were strongly increased upon vaccination with insoluble PsaA i.e. PsaA displayed on PHB beads. Particulate PsaA-PHB beads elicited IgG antibodies recognizing PsaA in whole cell lysates of seven different serotypes of S. pneumoniae. This study suggested that PHB beads are suitable carriers for PsaA in order to induce a significant and specific Th-2-type immune response.

Research paper thumbnail of Influence of the Co-Administration of Heptavalent Conjugate Vaccine PCV7-TT on the Immunological Response Elicited by VA-MENGOC-BC® and Heberpenta®-L in Rabbits

Immunological Investigations, 2017

Finlay Vaccine Institute is developing a new heptavalent conjugate vaccine against Streptococcus ... more Finlay Vaccine Institute is developing a new heptavalent conjugate vaccine against Streptococcus pneumoniae. As infants are the target population, PCV7-TT will be necessarily co-administered with other vaccines, and then, the interactions represent a concern. The aim of this work is to evaluate the possible immunological interferences in rabbits as animal experimental model. Rabbits were immunized with Heberpenta®-L, VA-MENGOC-BC®, and PCV7-TT. Blood samples were taken fourteen days after final immunization for obtaining sera. Antibody responses to all antigens were evaluated by indirect ELISA. Functional responses against diphtheria and tetanus toxoid were done by in vivo seroneutralization assay. No interference was observed by PCV7-TT over the humoral response against diphtheria toxoid and meningococcal antigens (p > 0.05). A nonstatistically significant reduction (p > 0.05) was observed in the case of the humoral response against Haemophilus influenzae type b oligosaccharide. Concomitant administration of Heberpenta®-L and PCV7-TT increased twice the antibody titers as well as the protective activity against tetanus toxoid, but no statistical differences were found. The co-administration did not induce a reduction in the percent of responders against pneumococcal polysaccharides contained in PCV7-TT vaccine. Concomitant administration of PCV7-TT did not induce interferences over the evaluated antigens of Heberpenta®-L and VA-MENGOC-BC®. Also, no interference was observed on the immune response elicited by PCV7-TT. These preclinical results suggest that PCV7-TT will not result in a serious problem over the immune response elicited by the licensed vaccines Heberpenta®-L and VA-MENGOC-BC®. However, the clinical interference could be strictly studied during clinical trials in infants.

Research paper thumbnail of Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age

The Pediatric Infectious Disease Journal, 2016

A new vaccine candidate against pneumococcus is being developed in Cuba, and it is a priority of ... more A new vaccine candidate against pneumococcus is being developed in Cuba, and it is a priority of the national health system. There is limited information on nasopharyngeal colonization burden, though it is essential for monitoring the impact of the vaccine. The study aims to estimate the prevalence of nasopharyngeal colonization in children 2-18 months of age and identify circulating serotypes, antimicrobial resistance and its association with selected risk factors. A cross-sectional study was conducted between October and December 2013 in Cienfuegos municipality. Inclusion criteria were evaluated, and informed consent was obtained from the parents. Clinical and epidemiologic data were collected through a semistructured questionnaire. Nasopharyngeal swabs according to established protocols were taken. Data analysis included frequency distributions and comparison of proportions. The association between colonization and selected risk factors was assessed by multivariate analysis. A total of 984 children (87.2% living in urban areas) were included. The overall prevalence of colonization was 21.6%. The most frequent serotypes isolated were 6A (23.1%), 23F (10.8%), 6B (10.3%), 19F (8.5%) and 14 (3.3%). We found no resistance to β-lactamases in circulating serotypes. Living with sibling younger than 5 years, previous respiratory infections, previous hospitalization and day-care attendance were determinants of nasopharyngeal carriage. The findings suggest that the burden of pneumococcal disease and colonization in Cuba could be significantly affected after vaccine introduction.

Research paper thumbnail of Efecto de la hemina-arginina y el QF12 en la incorporación de 59 Fe en los eritrocitos de ratones

Revista Cubana De Hematologia Inmunologia Y Hemoterapia, Apr 1, 2006

Research paper thumbnail of Vaccines against Bacterial Pathogens: A General Overview

An Overview on Structure, Biological Roles, Synthetic Methods and Application as Therapeutics, 2015

Research paper thumbnail of El reto en la terapia antioxidante

Research paper thumbnail of Procedimiento de conjugación del polisacárido capsular de Streptococcus pneumoniae serotipo 6B a toxoide tetánico

Biotecnologia Aplicada

Streptococcus pneumoniae causes annually 826 000 deaths in children under five years. The serotyp... more Streptococcus pneumoniae causes annually 826 000 deaths in children under five years. The serotype 6B, one of higher incidence, is targeted by the Cuban research and development project to develop a conjugate vaccine. There is limited data on how modifications caused by conjugation affect the physicochemical and antigenic characteristics of polysaccharides, particularly for serotype 6B capsular polysaccharide (PS6B), despite being the least immunogenic among S. pneumoniae polysaccharides. In this work, a conjugation procedure was established for PS6B comprising: fragmentation by acid hydrolysis, activation by periodate oxidation, and conjugation to tetanus toxoid (TT) by reductive amination to increase its immunogenicity. Reaction conditions were set to obtain the polysaccharide in three molecular size ranges (1-10, 10-30, 30-100 kDa) and levels of oxidation. PS6B fragmentation below 10 kDa and oxidation above 24 % of the repetitive units implied the loss of antigenicity. Polysaccha...

Research paper thumbnail of Caracterización de conjugados inmunogénicos de polisacárido capsular Streptococcus pneumoniae serotipo 14

Research paper thumbnail of New Cuban natural product from stem bark of Mangifera indica L (VIMANG). Pharmacological profile and therapeutic potentiality

Research paper thumbnail of The paradox of natural products as pharmaceuticals. Experimental evidences of a mango stem bark extract

Research paper thumbnail of Utility of Vimang® formulations in patients with knee osteoarthrosis | Utilidad de las formulaciones Vimang® en pacientes con osteoartrosis de rodilla

Research paper thumbnail of Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial

Research paper thumbnail of Immune Response to Streptomyces lividans in Mice: A Potential Vaccine Vehicle Against TB

The Open Vaccine Journal, 2009

Research paper thumbnail of Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide

Research paper thumbnail of Anthelminthic and antiallergic activities ofMangifera indica L. stem bark components Vimang and mangiferin

Phytotherapy Research, 2003

Research paper thumbnail of Mangifera indica L. extract (Vimang) and mangiferin modulate mouse humoral immune responses

Phytotherapy Research, 2003

Research paper thumbnail of Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production on macrophages and microglia by a standard aqueous extract of Mangifera indica L. (VIMANGS)Role of mangiferin isolated from the extract

Pharmacological Research, 2004

Research paper thumbnail of In vivo and in vitro anti-inflammatory activity of Harrisonia perforata root extract

Pharmacognosy Journal, 2012

Research paper thumbnail of From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, Jan 27, 2017

A new pneumococcal conjugate vaccine is currently undergoing advanced clinical evaluation prior t... more A new pneumococcal conjugate vaccine is currently undergoing advanced clinical evaluation prior to its planned introduction in Cuba. The implementation of the pneumococcal vaccination strategy has been designed with consideration of the need to maximize both its direct and indirect effects. A novel approach is suggested, which addresses preschool children as the first-line target group to generate herd immunity in infants and to have an impact on transmission at the community level. The clinical evaluation pipeline is described herein, including evaluations of effectiveness, cost-effectiveness, and impact. The scientific contribution of the Cuban strategy could support a paradigm shift from individual protection to a population effect based on a rigorous body of scientific evidence.

Research paper thumbnail of Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2–18 Months of Age Baseline Study Pre Introduction of Pneumococcal Vaccination in Cuba

Background: A new vaccine candidate against pneumococcus is being developed in Cuba, and it is a ... more Background: A new vaccine candidate against pneumococcus is being
developed in Cuba, and it is a priority of the national health system. There is limited information on nasopharyngeal colonization burden, though it is essential for monitoring the impact of the vaccine. The study aims to estimate the prevalence of nasopharyngeal colonization in children 2–18 months of age and identify circulating serotypes, antimicrobial resistance and its association with selected risk factors.
Methods: A cross-sectional study was conducted between October and December 2013 in Cienfuegos municipality. Inclusion criteria were evaluated, and informed consent was obtained from the parents. Clinical and epidemiologic data were collected through a semistructured questionnaire. Nasopharyngeal swabs according to established protocols were taken. Data analysis included frequency
distributions and comparison of proportions. The association between
colonization and selected risk factors was assessed by multivariate analysis.
Results: A total of 984 children (87.2% living in urban areas) were included. The overall prevalence of colonization was 21.6%. The most frequent serotypes isolated were 6A (23.1%), 23F (10.8%), 6B (10.3%), 19F (8.5%) and 14 (3.3%). We found no resistance to β-lactamases in circulating serotypes. Living with sibling younger than 5 years, previous respiratory infections, previous hospitalization and day-care attendance were determinants of nasopharyngeal carriage.
Conclusions: The findings suggest that the burden of pneumococcal disease and colonization in Cuba could be significantly affected after vaccine introduction.

Research paper thumbnail of Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection

Heliyon, 2017

Streptococcus pneumoniae is a human pathogen responsible for the majority of childhood pneumonia ... more Streptococcus pneumoniae is a human pathogen responsible for the majority of childhood pneumonia and media otitis cases worldwide. The diversity of its capsular polysaccharides (CPS) results in more than 91 serotypes of which at least 23 are virulent. Various CPS conjugated to immunogenic carrier proteins are currently licensed and provide protection against the infection caused by the respective serotypes but not against new and emerging virulent serotypes. In this study, we considered the conserved protein antigen PsaA, the pneumococcal surface adhesin A, in order to overcome the limitations of CPS antigens. The PsaA was translationally fused to a polyhydroxybutyrate (PHB) synthase which mediated production of PsaA displayed on PHB inclusions in recombinant Escherichia coli. This suggested that the PsaA fusion to the PHB synthase did not interfere with PHB synthase activity and its ability to mediate formation of nano-sized inclusions composed of a PHB core surrounded by the PHB synthase fused to PsaA. Isolated PHB beads showed a negative surface charge. Transmission electron microscopy analysis suggested that the PsaA fusion to the PHB synthase reduced the size of PHB beads from about 500 nm to 100 nm. The integrity and antigenicity of the fusion protein attached to isolated PHB beads was confirmed by SDS-PAGE, tryptic peptide fingerprinting analysis using MALDI-TOF-MS/MS and immunoblotting using a monoclonal anti-PsaA antibody. Mice immunized with PsaA displaying PHB beads produced high and specific IgG levels dominated by IgG1 isotype. While IgG1 titer were similar between soluble and insoluble PsaA, the IgG2 titers were strongly increased upon vaccination with insoluble PsaA i.e. PsaA displayed on PHB beads. Particulate PsaA-PHB beads elicited IgG antibodies recognizing PsaA in whole cell lysates of seven different serotypes of S. pneumoniae. This study suggested that PHB beads are suitable carriers for PsaA in order to induce a significant and specific Th-2-type immune response.

Research paper thumbnail of Influence of the Co-Administration of Heptavalent Conjugate Vaccine PCV7-TT on the Immunological Response Elicited by VA-MENGOC-BC® and Heberpenta®-L in Rabbits

Immunological Investigations, 2017

Finlay Vaccine Institute is developing a new heptavalent conjugate vaccine against Streptococcus ... more Finlay Vaccine Institute is developing a new heptavalent conjugate vaccine against Streptococcus pneumoniae. As infants are the target population, PCV7-TT will be necessarily co-administered with other vaccines, and then, the interactions represent a concern. The aim of this work is to evaluate the possible immunological interferences in rabbits as animal experimental model. Rabbits were immunized with Heberpenta®-L, VA-MENGOC-BC®, and PCV7-TT. Blood samples were taken fourteen days after final immunization for obtaining sera. Antibody responses to all antigens were evaluated by indirect ELISA. Functional responses against diphtheria and tetanus toxoid were done by in vivo seroneutralization assay. No interference was observed by PCV7-TT over the humoral response against diphtheria toxoid and meningococcal antigens (p > 0.05). A nonstatistically significant reduction (p > 0.05) was observed in the case of the humoral response against Haemophilus influenzae type b oligosaccharide. Concomitant administration of Heberpenta®-L and PCV7-TT increased twice the antibody titers as well as the protective activity against tetanus toxoid, but no statistical differences were found. The co-administration did not induce a reduction in the percent of responders against pneumococcal polysaccharides contained in PCV7-TT vaccine. Concomitant administration of PCV7-TT did not induce interferences over the evaluated antigens of Heberpenta®-L and VA-MENGOC-BC®. Also, no interference was observed on the immune response elicited by PCV7-TT. These preclinical results suggest that PCV7-TT will not result in a serious problem over the immune response elicited by the licensed vaccines Heberpenta®-L and VA-MENGOC-BC®. However, the clinical interference could be strictly studied during clinical trials in infants.

Research paper thumbnail of Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age

The Pediatric Infectious Disease Journal, 2016

A new vaccine candidate against pneumococcus is being developed in Cuba, and it is a priority of ... more A new vaccine candidate against pneumococcus is being developed in Cuba, and it is a priority of the national health system. There is limited information on nasopharyngeal colonization burden, though it is essential for monitoring the impact of the vaccine. The study aims to estimate the prevalence of nasopharyngeal colonization in children 2-18 months of age and identify circulating serotypes, antimicrobial resistance and its association with selected risk factors. A cross-sectional study was conducted between October and December 2013 in Cienfuegos municipality. Inclusion criteria were evaluated, and informed consent was obtained from the parents. Clinical and epidemiologic data were collected through a semistructured questionnaire. Nasopharyngeal swabs according to established protocols were taken. Data analysis included frequency distributions and comparison of proportions. The association between colonization and selected risk factors was assessed by multivariate analysis. A total of 984 children (87.2% living in urban areas) were included. The overall prevalence of colonization was 21.6%. The most frequent serotypes isolated were 6A (23.1%), 23F (10.8%), 6B (10.3%), 19F (8.5%) and 14 (3.3%). We found no resistance to β-lactamases in circulating serotypes. Living with sibling younger than 5 years, previous respiratory infections, previous hospitalization and day-care attendance were determinants of nasopharyngeal carriage. The findings suggest that the burden of pneumococcal disease and colonization in Cuba could be significantly affected after vaccine introduction.

Research paper thumbnail of Efecto de la hemina-arginina y el QF12 en la incorporación de 59 Fe en los eritrocitos de ratones

Revista Cubana De Hematologia Inmunologia Y Hemoterapia, Apr 1, 2006

Research paper thumbnail of Vaccines against Bacterial Pathogens: A General Overview

An Overview on Structure, Biological Roles, Synthetic Methods and Application as Therapeutics, 2015

Research paper thumbnail of El reto en la terapia antioxidante

Research paper thumbnail of Procedimiento de conjugación del polisacárido capsular de Streptococcus pneumoniae serotipo 6B a toxoide tetánico

Biotecnologia Aplicada

Streptococcus pneumoniae causes annually 826 000 deaths in children under five years. The serotyp... more Streptococcus pneumoniae causes annually 826 000 deaths in children under five years. The serotype 6B, one of higher incidence, is targeted by the Cuban research and development project to develop a conjugate vaccine. There is limited data on how modifications caused by conjugation affect the physicochemical and antigenic characteristics of polysaccharides, particularly for serotype 6B capsular polysaccharide (PS6B), despite being the least immunogenic among S. pneumoniae polysaccharides. In this work, a conjugation procedure was established for PS6B comprising: fragmentation by acid hydrolysis, activation by periodate oxidation, and conjugation to tetanus toxoid (TT) by reductive amination to increase its immunogenicity. Reaction conditions were set to obtain the polysaccharide in three molecular size ranges (1-10, 10-30, 30-100 kDa) and levels of oxidation. PS6B fragmentation below 10 kDa and oxidation above 24 % of the repetitive units implied the loss of antigenicity. Polysaccha...

Research paper thumbnail of Caracterización de conjugados inmunogénicos de polisacárido capsular Streptococcus pneumoniae serotipo 14

Research paper thumbnail of New Cuban natural product from stem bark of Mangifera indica L (VIMANG). Pharmacological profile and therapeutic potentiality

Research paper thumbnail of The paradox of natural products as pharmaceuticals. Experimental evidences of a mango stem bark extract

Research paper thumbnail of Utility of Vimang® formulations in patients with knee osteoarthrosis | Utilidad de las formulaciones Vimang® en pacientes con osteoartrosis de rodilla

Research paper thumbnail of Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial

Research paper thumbnail of Immune Response to Streptomyces lividans in Mice: A Potential Vaccine Vehicle Against TB

The Open Vaccine Journal, 2009

Research paper thumbnail of Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide

Research paper thumbnail of Anthelminthic and antiallergic activities ofMangifera indica L. stem bark components Vimang and mangiferin

Phytotherapy Research, 2003

Research paper thumbnail of Mangifera indica L. extract (Vimang) and mangiferin modulate mouse humoral immune responses

Phytotherapy Research, 2003

Research paper thumbnail of Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production on macrophages and microglia by a standard aqueous extract of Mangifera indica L. (VIMANGS)Role of mangiferin isolated from the extract

Pharmacological Research, 2004

Research paper thumbnail of In vivo and in vitro anti-inflammatory activity of Harrisonia perforata root extract

Pharmacognosy Journal, 2012